These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 17719188)

  • 21. Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.
    Platt R; Vincent AL; Gauger PC; Loving CL; Zanella EL; Lager KM; Kehrli ME; Kimura K; Roth JA
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):252-7. PubMed ID: 21664701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.
    Sui J; Yang D; Qiao C; Xu H; Xu B; Wu Y; Yang H; Chen Y; Chen H
    Vaccine; 2016 Jul; 34(33):3757-63. PubMed ID: 27321744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal vaccination against influenza: protection of pigs immunized with inactivated virus and ether-split vaccine.
    Lim YK; Takada A; Tanizaki T; Ozaki H; Okazaki K; Kida H
    Jpn J Vet Res; 2001 Feb; 48(4):197-203. PubMed ID: 11276584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
    Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
    Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
    Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
    Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype.
    Van Reeth K; Van Gucht S; Pensaert M
    Vet Rec; 2003 Jul; 153(1):9-13. PubMed ID: 12877210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus.
    Loeffen WL; de Vries RP; Stockhofe N; van Zoelen-Bos D; Maas R; Koch G; Moormann RJ; Rottier PJ; de Haan CA
    Vaccine; 2011 Feb; 29(8):1545-50. PubMed ID: 21219983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
    Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
    Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.
    Rajão DS; Loving CL; Gauger PC; Kitikoon P; Vincent AL
    Vaccine; 2014 Sep; 32(40):5170-6. PubMed ID: 25077416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
    Kappes MA; Sandbulte MR; Platt R; Wang C; Lager KM; Henningson JN; Lorusso A; Vincent AL; Loving CL; Roth JA; Kehrli ME
    Vaccine; 2012 Jan; 30(2):280-8. PubMed ID: 22067263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
    Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
    Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.
    Magiri R; Lai K; Chaffey A; Zhou Y; Pyo HM; Gerdts V; Wilson HL; Mutwiri G
    Vaccine; 2018 Mar; 36(12):1606-1613. PubMed ID: 29454517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection.
    Pyo HM; Zhou Y
    Vaccine; 2014 Jun; 32(30):3835-42. PubMed ID: 24837774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.
    Van Reeth K; Gregory V; Hay A; Pensaert M
    Vaccine; 2003 Mar; 21(13-14):1375-81. PubMed ID: 12615433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
    Baras B; de Waal L; Stittelaar KJ; Jacob V; Giannini S; Kroeze EJ; van den Brand JM; van Amerongen G; Simon JH; Hanon E; Mossman SP; Osterhaus AD
    Vaccine; 2011 Mar; 29(11):2120-6. PubMed ID: 21238573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.